You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: February 7, 2025

Drug Price Trends for GNP COUGH-COLD HBP TABLET


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for GNP COUGH-COLD HBP TABLET

Average Pharmacy Cost for GNP COUGH-COLD HBP TABLET

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
GNP COUGH-COLD HBP TABLET 46122-0705-73 0.09616 EACH 2025-01-22
GNP COUGH-COLD HBP TABLET 46122-0705-73 0.10119 EACH 2024-12-18
GNP COUGH-COLD HBP TABLET 46122-0705-73 0.10392 EACH 2024-11-20
GNP COUGH-COLD HBP TABLET 46122-0705-73 0.10319 EACH 2024-10-23
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Market Analysis and Price Projections for Coricidin HBP Cough & Cold Tablets

Market Context

The market for cough and cold medications, particularly those formulated for individuals with high blood pressure (HBP), is a niche but significant segment within the broader pharmaceutical industry. Coricidin HBP Cough & Cold Tablets are a prominent product in this category, designed to provide relief from cough, runny nose, and sneezing without the use of decongestants, which can be problematic for people with high blood pressure[1][5].

Target Market

The primary target market for Coricidin HBP Cough & Cold Tablets includes individuals suffering from high blood pressure who require effective cough and cold relief. This demographic is substantial, given the prevalence of hypertension and the frequent need for cold and cough medications.

Competitive Landscape

The cough suppressant drugs market is competitive, with several brands offering various formulations. However, Coricidin HBP stands out as the #1 brand for powerful cold symptom relief specifically formulated for people with high blood pressure. Other competitors include Mucinex DM and Tuzistra XR, but these may not be as tailored to the HBP demographic[4][5].

Market Size and Growth

The global cough suppressant drugs market was valued at US$ 1100.4 Mn in 2017 and is expected to grow at a CAGR of 3.7% from 2018 to 2026. North America is anticipated to hold a dominant position in this market due to frequent FDA approvals of new cough suppressant drugs[4].

Price Analysis

The cost for Coricidin HBP Cough & Cold Tablets is around $15 for a supply of 16 tablets, depending on the pharmacy. This price can be reduced using discount cards, such as the Drugs.com Discount Card, which can save up to 80% off the cost of prescription and over-the-counter medications[2].

Pricing Projections

Given the stable demand for cough and cold medications and the specific need for HBP-friendly options, the prices of Coricidin HBP Cough & Cold Tablets are likely to remain relatively stable. Here are some key points to consider:

  • Current Pricing: The current price range is around $14.75 to $15 for 16 tablets.
  • Discounts and Coupons: The use of discount cards and coupons can significantly reduce the cost, making the product more accessible to a wider audience.
  • Market Trends: The overall market for cough suppressant drugs is growing, but this does not necessarily translate to higher prices. Instead, it may lead to increased competition and potentially stable or slightly reduced prices.

Consumer Behavior and Demand

Cough is one of the most common reasons for visits to primary care physicians globally, accounting for around 8% of all consultations. The annual prevalence of cough in the general population is approximately 10–33% globally. This high demand ensures a consistent market for cough and cold medications, including those specifically formulated for individuals with high blood pressure[4].

Product Features and Benefits

Coricidin HBP Cough & Cold Tablets offer several key benefits:

  • Decongestant-Free: This is crucial for individuals with high blood pressure, as decongestants can raise blood pressure or interfere with blood pressure medications.
  • Fast and Powerful Relief: Provides quick relief from cough, runny nose, and sneezing.
  • Formulation: Available in tablet form, which is convenient for many users[1][5].

Regulatory Environment

The FDA plays a significant role in the approval and regulation of cough suppressant drugs. Recent approvals, such as those for Mucinex DM Maximum Strength and Tuzistra XR, indicate a favorable regulatory environment for innovative cough and cold medications. However, Coricidin HBP Cough & Cold Tablets must comply with FDA regulations and guidelines to maintain their market position[4].

Economic Factors

The cost of healthcare and the prevalence of cardiovascular diseases are driving factors in the hypertension drug market, which indirectly influences the demand for HBP-friendly cough and cold medications. The economic benefits associated with effective hypertension management also support the growth of this niche market[3].

Technological Advancements

Technological advancements in drug formulation and delivery systems can impact the market. For instance, extended-release formulations and innovative delivery methods can enhance the efficacy and safety of cough suppressant drugs, potentially influencing consumer preferences and market dynamics[3].

Key Takeaways

  • Stable Demand: The demand for cough and cold medications, especially those tailored for individuals with high blood pressure, remains consistent.
  • Competitive Pricing: Prices are likely to remain stable or slightly reduce due to market competition and the availability of discount programs.
  • Regulatory Compliance: Compliance with FDA regulations is crucial for maintaining market presence.
  • Consumer Benefits: Decongestant-free formulations and fast, powerful relief are key selling points.

Frequently Asked Questions (FAQs)

Q: What makes Coricidin HBP Cough & Cold Tablets unique? A: These tablets are specifically formulated for individuals with high blood pressure, providing relief from cough, runny nose, and sneezing without the use of decongestants.

Q: How much do Coricidin HBP Cough & Cold Tablets cost? A: The cost is around $15 for a supply of 16 tablets, but prices can be reduced using discount cards.

Q: Are there any discounts available for Coricidin HBP Cough & Cold Tablets? A: Yes, discount cards like the Drugs.com Discount Card can save up to 80% off the cost.

Q: What is the market outlook for cough suppressant drugs? A: The market is expected to grow at a CAGR of 3.7% from 2018 to 2026, driven by frequent FDA approvals and high demand.

Q: Why is it important for people with high blood pressure to avoid decongestants? A: Decongestants can raise blood pressure or interfere with the effectiveness of some prescribed blood pressure medications, according to the American Heart Association[1].

Cited Sources:

  1. Rite Aid - Coricidin HBP for Cough & Cold Tablets.
  2. Drugs.com - Coricidin HBP Cough & Cold Prices, Coupons, Copay Cards.
  3. Polaris Market Research - Hypertension Drug Market Share, Size, Trends Report.
  4. Coherent Market Insights - Cough Suppressant Drugs Market.
  5. Coricidin - Coricidin® HBP Cough & Cold.

More… ↓

⤷  Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.